Hackinger S, Kraaijenbrink T, Xue Y, Mezzavilla M, van Driem G, Jobling MA, de Knijff P, Tyler-Smith C, Ayub Q
Eli Lilly and Company is the pharmaceutical company that makes two tirzepatide products that are approved by the Food and Drug Administration (FDA): Mounjaro, which is approved by the FDA for improving blood sugar levels in people with Type 2 diabetes, and is often prescribed off-label for weight loss Zepbound, which is FDA approved for weight loss, as well as for obstructive sleep apnea in adults with obesity Currently, there are no FDA-approved generic versions of the drugs Mounjaro or Zepbound, and there are not any other FDA-approved tirzepatide products available besides brand-name Mounjaro and Zepbound
10.1016/j.cub.2014.03.034 Curr
[2] If you notice any of these symptoms or experience any adverse effects, stop using your liraglutide treatment and contact your health care provider immediately by calling 911 or going to your local emergency department